ABCC11 antibodies are immunodetection reagents targeting the ABCC11 protein, a multidrug resistance-associated transporter (MRP8) encoded by the ABCC11 gene. This protein facilitates ATP-dependent transport of lipophilic anions, including bile acids, steroid conjugates, and cyclic nucleotides (cAMP/cGMP), and is linked to earwax type determination and axillary odor formation .
Epitope: Most ABCC11 antibodies target specific regions, such as the intracellular domain (residues A747–H795) or the N-terminal region (residues 343–372) .
Host: Polyclonal antibodies are typically raised in rabbits using KLH-conjugated synthetic peptides .
Validation: Specificity is confirmed via immunoblotting in ABCC11-transfected cells or tissues. For example, the antibody 09YT demonstrated specificity in transgenic mice and human apocrine glands .
ABCC11 antibodies are widely used in:
Drug Resistance: ABCC11 overexpression correlates with resistance to eribulin (breast cancer) and 5-fluorouracil (colon cancer) .
Metastasis: ABCC11-negative tumors exhibit higher lymph node metastasis and venous invasion rates .
Genetic Polymorphism: The ABCC11 538G>A SNP reduces protein stability via endoplasmic reticulum-associated degradation (ERAD), impacting axillary odor and earwax type .
Glycosylation Sensitivity: ABCC11’s mature glycosylated form is detectable via N-glycosidase treatment .
Species Reactivity: Most antibodies are validated for human samples, with predicted reactivity in bovine and canine models .
Storage: Long-term storage at -20°C in aliquots to prevent freeze-thaw cycles .
Here’s a structured collection of FAQs tailored for academic researchers working with ABCC11 antibodies, synthesized from peer-reviewed studies and technical documentation:
Troubleshooting framework:
Stepwise approach:
Protocol refinement:
Pre-amplification: Perform tyramide signal amplification (TSA) for IHC .
Multiplexing: Combine ABCC11 antibody with fluorescent-conjugated secondary antibodies and nuclear counterstains (e.g., DAPI) .
Quantitative analysis: Use densitometry software (e.g., ImageJ) with α-Tubulin/GAPDH normalization .
Critical factors:
Discrimination strategies: